Core Viewpoint - The company achieved a revenue of 36.01 billion with a year-on-year growth of 12.8% and a net profit attributable to shareholders of 12.24 billion, reflecting a year-on-year increase of 17.3% in 2024. The company is entering the second phase of its revitalization plan for Fenjiu in 2025, aiming for steady long-term development [1]. Financial Performance - In 2024, the company reported a revenue of 36.01 billion (up 12.8% YoY) and a net profit of 12.24 billion (up 17.3% YoY). In Q4 2024, revenue was 4.65 billion (down 10.2% YoY) and net profit was 0.89 billion (down 11.3% YoY). For Q1 2025, revenue reached 16.52 billion (up 7.7% YoY) and net profit was 6.65 billion (up 6.2% YoY), aligning with previous expectations [1][4]. Product and Market Strategy - The company is focusing on mid-to-high-end products, with revenue from these segments reaching 26.53 billion and 9.34 billion respectively in 2024, showing growth of 14.4% and 9.4% YoY. The company anticipates that its mid-tier product, Laobai Fen, will be a significant growth driver in the second phase of its strategy [2]. - The company’s revenue from provincial and non-provincial markets in 2024 was 13.50 billion and 22.37 billion respectively, with growth rates of 11.7% and 13.8% YoY. The non-provincial revenue share increased by 0.4 percentage points YoY, indicating ongoing optimization of its national layout [2]. Cost and Profitability Analysis - The gross profit margin for 2024 improved by 0.9 percentage points to 76.2%, driven by strong performance in the Qinghua and mid-tier products. In Q1 2025, the gross profit margin further increased by 1.3 percentage points to 78.8% [3]. - The net profit margin for 2024 rose by 1.3 percentage points to 34.0%. However, in Q1 2025, the net profit margin decreased by 0.6 percentage points to 40.2% due to increased sales and management expenses [3]. Future Outlook and Valuation - The company successfully completed the first phase of its revitalization plan and is progressing steadily into the second phase. However, external demand recovery is expected to take time, leading to a downward revision of revenue forecasts for 2025 and 2026 by 6% and 9% respectively. The estimated EPS for 2025 and 2026 is projected at 11.15 and 12.60 respectively [4]. - The target price for the company is set at 256.45, based on a 23x PE ratio for 2025, reflecting the company's potential for national expansion [4].
山西汾酒(600809):腰部产品发力 全国布局优化